Specifically, complex IV activity was found decreased in skeletal muscle from ALS patients [29] and the inhibition of complex I and II in hind- and forelimb muscles are key molecular signatures during early- and late-stage disease progression in the SOD1 G93A mouse model [39]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.